Description
Gusacitinib is a dual inhibitor of SYK/JAK kinases.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Gusacitinib is a dual inhibitor of SYK/JAK kinases.
| Cas No. | 1425381-60-7 |
|---|---|
| Purity | ≥98% |
| Formula | C24H28N8O2 |
| Formula Wt. | 460.54 |
| IUPAC Name | 2-[1-[4-[4-(4-hydroxypiperidin-1-yl)anilino]-5-oxo-6H-pyrimido[4,5-d]pyridazin-2-yl]piperidin-4-yl]acetonitrile |
| Synonym | ASN-002, ASN002 |
| Appearance | Yellow powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Montilla A, Gomez-Garcia F, Gomez-Arias P, et al. Scoping review on the use of drugs targeting JAK/STAT pathway in atopic dermatitis, vitiligo, and alopecia areata. Dermatol The (Heidelb). 2019 Dec;9(4):655-683. PMID: 31606872
Cell membrane permeability modulator, topoisome...
Macrolide; F1F0 ATP synthase inhibitor.
Polymixin, antimicrobial peptide, induces forma...
Water-soluble parthenolide analog; NF-κB inhib...
Dual RAF/EGFR inhibitor.
CDK9 inhibitor.
Coccidiostat; dihydrofolate reductase inhibitor...
Non-fluorescent halogenated A23187 analog, Ca2+...
CRTH2 inhibitor.
mAChR antagonist.
Pt-based DNA cross-linker.
Antimicrobial peptide.
Thienylbutyl ITC analog.
PPARγ agonist, AT1 inhibitor.
Loop diuretic; NKCC symporter and HSP90 inhibit...
PORCN inhibitor.
Impurity of diclofenac
PLK1 inhibitor.
SARS-CoV-2 inhibitor
Mycotoxin produced by species of Aspergillus; D...